Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Invested Capital: 2010-2024

Historic Invested Capital for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to $8.9 million.

  • China Pharma Holdings' Invested Capital rose 35.67% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year increase of 35.67%. This contributed to the annual value of $8.9 million for FY2024, which is 3.54% up from last year.
  • Per China Pharma Holdings' latest filing, its Invested Capital stood at $8.9 million for FY2024, which was up 3.54% from $8.6 million recorded in FY2023.
  • China Pharma Holdings' Invested Capital's 5-year high stood at $10.3 million during FY2021, with a 5-year trough of $4.7 million in FY2022.
  • In the last 3 years, China Pharma Holdings' Invested Capital had a median value of $8.6 million in 2023 and averaged $7.4 million.
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 54.29% in 2022, then spiked by 81.57% in 2023.
  • Over the past 5 years, China Pharma Holdings' Invested Capital (Yearly) stood at $10.0 million in 2020, then climbed by 3.03% to $10.3 million in 2021, then crashed by 54.29% to $4.7 million in 2022, then skyrocketed by 81.57% to $8.6 million in 2023, then rose by 3.54% to $8.9 million in 2024.